{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T22:08:33Z","timestamp":1789164513720,"version":"build-2803163510"},"reference-count":43,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Yunnan Fundamental Research Project","award":["202301AT070132"],"award-info":[{"award-number":["202301AT070132"]}]},{"name":"Yunnan Fundamental Research Project","award":["202301AT070127"],"award-info":[{"award-number":["202301AT070127"]}]},{"name":"Yunnan Fundamental Research Project","award":["202301AY070001-141"],"award-info":[{"award-number":["202301AY070001-141"]}]},{"name":"Yunnan Fundamental Research Project","award":["82360328"],"award-info":[{"award-number":["82360328"]}]},{"name":"Yunnan Fundamental Research Project","award":["2024535Q01"],"award-info":[{"award-number":["2024535Q01"]}]},{"name":"Yunnan Fundamental Research Project","award":["2021BS004"],"award-info":[{"award-number":["2021BS004"]}]},{"name":"Joint Special Fund of the Department of Science and Technology of Yunnan Province\u2013Kunming Medical University","award":["202301AT070132"],"award-info":[{"award-number":["202301AT070132"]}]},{"name":"Joint Special Fund of the Department of Science and Technology of Yunnan Province\u2013Kunming Medical University","award":["202301AT070127"],"award-info":[{"award-number":["202301AT070127"]}]},{"name":"Joint Special Fund of the Department of Science and Technology of Yunnan Province\u2013Kunming Medical University","award":["202301AY070001-141"],"award-info":[{"award-number":["202301AY070001-141"]}]},{"name":"Joint Special Fund of the Department of Science and Technology of Yunnan Province\u2013Kunming Medical University","award":["82360328"],"award-info":[{"award-number":["82360328"]}]},{"name":"Joint Special Fund of the Department of Science and Technology of Yunnan Province\u2013Kunming Medical University","award":["2024535Q01"],"award-info":[{"award-number":["2024535Q01"]}]},{"name":"Joint Special Fund of the Department of Science and Technology of Yunnan Province\u2013Kunming Medical University","award":["2021BS004"],"award-info":[{"award-number":["2021BS004"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["202301AT070132"],"award-info":[{"award-number":["202301AT070132"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["202301AT070127"],"award-info":[{"award-number":["202301AT070127"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["202301AY070001-141"],"award-info":[{"award-number":["202301AY070001-141"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360328"],"award-info":[{"award-number":["82360328"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2024535Q01"],"award-info":[{"award-number":["2024535Q01"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2021BS004"],"award-info":[{"award-number":["2021BS004"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"535 Talent Project of First Affiliated Hospital of Kunming Medical University","award":["202301AT070132"],"award-info":[{"award-number":["202301AT070132"]}]},{"name":"535 Talent Project of First Affiliated Hospital of Kunming Medical University","award":["202301AT070127"],"award-info":[{"award-number":["202301AT070127"]}]},{"name":"535 Talent Project of First Affiliated Hospital of Kunming Medical University","award":["202301AY070001-141"],"award-info":[{"award-number":["202301AY070001-141"]}]},{"name":"535 Talent Project of First Affiliated Hospital of Kunming Medical University","award":["82360328"],"award-info":[{"award-number":["82360328"]}]},{"name":"535 Talent Project of First Affiliated Hospital of Kunming Medical University","award":["2024535Q01"],"award-info":[{"award-number":["2024535Q01"]}]},{"name":"535 Talent Project of First Affiliated Hospital of Kunming Medical University","award":["2021BS004"],"award-info":[{"award-number":["2021BS004"]}]},{"name":"Doctor Scientific Research Startup Funds of the First Affiliated Hospital of Kunming Medical University","award":["202301AT070132"],"award-info":[{"award-number":["202301AT070132"]}]},{"name":"Doctor Scientific Research Startup Funds of the First Affiliated Hospital of Kunming Medical University","award":["202301AT070127"],"award-info":[{"award-number":["202301AT070127"]}]},{"name":"Doctor Scientific Research Startup Funds of the First Affiliated Hospital of Kunming Medical University","award":["202301AY070001-141"],"award-info":[{"award-number":["202301AY070001-141"]}]},{"name":"Doctor Scientific Research Startup Funds of the First Affiliated Hospital of Kunming Medical University","award":["82360328"],"award-info":[{"award-number":["82360328"]}]},{"name":"Doctor Scientific Research Startup Funds of the First Affiliated Hospital of Kunming Medical University","award":["2024535Q01"],"award-info":[{"award-number":["2024535Q01"]}]},{"name":"Doctor Scientific Research Startup Funds of the First Affiliated Hospital of Kunming Medical University","award":["2021BS004"],"award-info":[{"award-number":["2021BS004"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Background: Herpes simplex virus 2 (HSV-2) is the primary cause of sexually transmitted genital ulcerative diseases, for which no effective prophylactic vaccine is currently available. However, the identification of appropriate targets for an HSV-2 mRNA vaccine remains an area requiring further investigation. Methods: The immunogenicity and protective effects of an HSV-2 UL41 mRNA vaccine were evaluated in a BALB\/c mouse model. The mice were intramuscularly immunized twice, followed by HSV-2 infection at 28 days post boost. Clinical signs were monitored daily, and the viral load and tissue inflammation were assessed on days 1, 4, and 7 post infection. Dendritic cell (DC) activation in spleen tissue was analyzed via transcriptome sequencing. Results: A comparison of the clinical, immunological, and pathological characteristics of the groups that were immunized with the UL41 mRNA vaccine and then infected with HSV2, along with the control groups, revealed that the vaccine elicited both cellular and humoral immunity, inhibited viral replication, suppressed the inflammatory response, and provided protective effects against the virus in vivo. Furthermore, in vitro assays of DC expansion revealed that the vaccine immunization increased the induction of DCs from splenic cells. Transcriptomic analysis of these DCs revealed the activation of immune signaling pathways. Conclusions: Our study suggests that the UL41 mRNA vaccine may provide effective protection against HSV-2-related diseases and holds promise as a potential mRNA vaccine candidate.<\/jats:p>","DOI":"10.3390\/vaccines13030271","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T03:18:22Z","timestamp":1741144702000},"page":"271","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Immunogenicity and Protective Efficacy of an mRNA Vaccine Targeting HSV-2 UL41 in Mice"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-5798-045X","authenticated-orcid":false,"given":"Tangwei","family":"Mou","sequence":"first","affiliation":[{"name":"Research Center for Clinical Medicine, First Affiliated Hospital of Kunming Medical University, Kunming 650032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9197-274X","authenticated-orcid":false,"given":"Yu","family":"Zhao","sequence":"additional","affiliation":[{"name":"Research Center for Clinical Medicine, First Affiliated Hospital of Kunming Medical University, Kunming 650032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Jia","sequence":"additional","affiliation":[{"name":"Research Center for Clinical Medicine, First Affiliated Hospital of Kunming Medical University, Kunming 650032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Cheng","family":"Gao","sequence":"additional","affiliation":[{"name":"Research Center for Clinical Medicine, First Affiliated Hospital of Kunming Medical University, Kunming 650032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-You","family":"Li","sequence":"additional","affiliation":[{"name":"Research Center for Clinical Medicine, First Affiliated Hospital of Kunming Medical University, Kunming 650032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1452-4388","authenticated-orcid":false,"given":"Yi-Qun","family":"Kuang","sequence":"additional","affiliation":[{"name":"Research Center for Clinical Medicine, First Affiliated Hospital of Kunming Medical University, Kunming 650032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(07)61908-4","article-title":"Genital herpes","volume":"370","author":"Gupta","year":"2007","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.idc.2023.02.011","article-title":"Genital Herpes Infection: Progress and Problems","volume":"37","author":"Qushair","year":"2023","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.clp.2021.03.003","article-title":"Neonatal Herpes Simplex Virus Disease: Updates and Continued Challenges","volume":"48","author":"Samies","year":"2021","journal-title":"Clin. Perinatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1053\/j.semperi.2018.02.004","article-title":"Neonatal herpes simplex virus infections","volume":"42","author":"Pinninti","year":"2018","journal-title":"Semin. Perinatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1056\/NEJM198108063050604","article-title":"Risk of recurrence after first episodes of genital herpes. Relation to HSV type and antibody response","volume":"305","author":"Reeves","year":"1981","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1056\/NEJMcp1603178","article-title":"CLINICAL PRACTICE. Genital Herpes","volume":"375","author":"Gnann","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_7","first-page":"685","article-title":"Vertical transmission of herpes simplex virus: An update","volume":"16","author":"Bhatta","year":"2018","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e29379","DOI":"10.1002\/jmv.29379","article-title":"Vertical mother-to-infant transmission of herpes simplex virus 2 is correlated with tropism due to mutations in viral UL13","volume":"96","author":"Shiraki","year":"2024","journal-title":"J. Med. Virol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S1473-3099(19)30470-0","article-title":"Global and regional estimates of the contribution of herpes simplex virus type 2 infection to HIV incidence: A population attributable fraction analysis using published epidemiological data","volume":"20","author":"Looker","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"ref_10","first-page":"100176","article-title":"Epidemiology of herpes simplex virus type 2 in Asia: A systematic review, meta-analysis, and meta-regression","volume":"12","author":"AlMukdad","year":"2021","journal-title":"Lancet Reg. Health. West. Pac."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e164317","DOI":"10.1172\/JCI164317","article-title":"HSV-2 triggers upregulation of MALAT1 in CD4+ T cells and promotes HIV latency reversal","volume":"133","author":"Pierce","year":"2023","journal-title":"J. Clin. Investig."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s13346-021-00924-7","article-title":"Development of vaccine formulations: Past, present, and future","volume":"11","author":"Fontana","year":"2021","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1016\/j.vaccine.2015.12.076","article-title":"Status of vaccine research and development of vaccines for herpes simplex virus","volume":"34","author":"Johnston","year":"2016","journal-title":"Vaccine"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1128\/JVI.07203-11","article-title":"Live attenuated herpes simplex virus 2 glycoprotein E deletion mutant as a vaccine candidate defective in neuronal spread","volume":"86","author":"Awasthi","year":"2012","journal-title":"J. Virol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1016\/j.vaccine.2010.01.030","article-title":"Construction and properties of a herpes simplex virus 2 dl5-29 vaccine candidate strain encoding an HSV-1 virion host shutoff protein","volume":"28","author":"Reszka","year":"2010","journal-title":"Vaccine"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.virol.2017.10.011","article-title":"Intramuscular delivery of replication-defective herpes simplex virus gives antigen expression in muscle syncytia and improved protection against pathogenic HSV-2 strains","volume":"513","author":"Diaz","year":"2018","journal-title":"Virology"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Retamal-D\u00edaz, A., Weiss, K.A., Tognarelli, E.I., Freire, M., Bueno, S.M., Herold, B.C., Jacobs, W.R., and Gonz\u00e1lez, P.A. (2017). US6 Gene Deletion in Herpes Simplex Virus Type 2 Enhances Dendritic Cell Function and T Cell Activation. Front. Immunol., 8.","DOI":"10.3389\/fimmu.2017.01523"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e02163-19","DOI":"10.1128\/JVI.02163-19","article-title":"Trivalent Glycoprotein Subunit Vaccine Prevents Neonatal Herpes Simplex Virus Mortality and Morbidity","volume":"94","author":"Patel","year":"2020","journal-title":"J. Virol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.vaccine.2015.10.137","article-title":"A novel HSV-2 subunit vaccine induces GLA-dependent CD4 and CD8 T cell responses and protective immunity in mice and guinea pigs","volume":"34","author":"Odegard","year":"2016","journal-title":"Vaccine"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"6470","DOI":"10.1016\/j.vaccine.2019.08.077","article-title":"Intranasal nanoemulsion-adjuvanted HSV-2 subunit vaccine is effective as a prophylactic and therapeutic vaccine using the guinea pig model of genital herpes","volume":"37","author":"Bernstein","year":"2019","journal-title":"Vaccine"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nature14189","article-title":"The biology of innate lymphoid cells","volume":"517","author":"Artis","year":"2015","journal-title":"Nature"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Bai, L., Xu, J., Zeng, L., Zhang, L., and Zhou, F. (2024). A review of HSV pathogenesis, vaccine development, and advanced applications. Mol. Biomed., 5.","DOI":"10.1186\/s43556-024-00199-7"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e00099-20","DOI":"10.1128\/MMBR.00099-20","article-title":"The Race between Host Antiviral Innate Immunity and the Immune Evasion Strategies of Herpes Simplex Virus 1","volume":"84","author":"Zhu","year":"2020","journal-title":"Microbiol. Mol. Biol. Rev. MMBR"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"7476","DOI":"10.1128\/JVI.72.9.7476-7483.1998","article-title":"Recognition of herpes simplex virus type 2 tegument proteins by CD4 T cells infiltrating human genital herpes lesions","volume":"72","author":"Koelle","year":"1998","journal-title":"J. Virol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"11422","DOI":"10.1128\/JVI.74.23.11422-11425.2000","article-title":"CD4 T-cell responses to herpes simplex virus type 2 major capsid protein VP5: Comparison with responses to tegument and envelope glycoproteins","volume":"74","author":"Koelle","year":"2000","journal-title":"J. Virol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e02414-16","DOI":"10.1128\/JVI.02414-16","article-title":"Herpes Simplex Virus 1 Abrogates the cGAS\/STING-Mediated Cytosolic DNA-Sensing Pathway via Its Virion Host Shutoff Protein, UL41","volume":"91","author":"Su","year":"2017","journal-title":"J. Virol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"9337","DOI":"10.1128\/JVI.77.17.9337-9345.2003","article-title":"Herpes simplex virus type 2 virion host shutoff protein regulates alpha\/beta interferon but not adaptive immune responses during primary infection in vivo","volume":"77","author":"Murphy","year":"2003","journal-title":"J. Virol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nri1996","article-title":"Steady-state and inflammatory dendritic-cell development","volume":"7","author":"Shortman","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1039\/D1CS00617G","article-title":"Emerging mRNA technologies: Delivery strategies and biomedical applications","volume":"51","author":"Xiao","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00018-018-2935-4","article-title":"mRNA as novel technology for passive immunotherapy","volume":"76","author":"Schlake","year":"2019","journal-title":"Cell Mol. Life Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41568-023-00586-2","article-title":"mRNA-based cancer therapeutics","volume":"23","author":"Liu","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.molmed.2018.11.003","article-title":"Systemic Administered mRNA as Therapy for Metabolic Diseases","volume":"25","author":"Puy","year":"2019","journal-title":"Trends Mol. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1146\/annurev-bioeng-110220-031722","article-title":"Current Developments and Challenges of mRNA Vaccines","volume":"24","author":"Chen","year":"2022","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"ref_34","first-page":"138","article-title":"Vaccines to prevent genital herpes","volume":"220","author":"Egan","year":"2020","journal-title":"Transl. Res. J. Lab. Clin. Med."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Cagigi, A., and Lor\u00e9, K. (2021). Immune Responses Induced by mRNA Vaccination in Mice, Monkeys and Humans. Vaccines, 9.","DOI":"10.3390\/vaccines9010061"},{"key":"ref_36","first-page":"56","article-title":"An mRNA vaccine to prevent genital herpes","volume":"242","author":"Awasthi","year":"2022","journal-title":"Transl. Res. J. Lab. Clin. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e1384","DOI":"10.1002\/ctm2.1384","article-title":"mRNA vaccine in cancer therapy: Current advance and future outlook","volume":"13","author":"Li","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s40265-021-01480-7","article-title":"BNT162b2 mRNA COVID-19 Vaccine: First Approval","volume":"81","author":"Lamb","year":"2021","journal-title":"Drugs"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Hook, L.M., Awasthi, S., Cairns, T.M., Alameh, M.G., Fowler, B.T., Egan, K.P., Sung, M.M.H., Weissman, D., Cohen, G.H., and Friedman, H.M. (2022). Antibodies to Crucial Epitopes on HSV-2 Glycoprotein D as a Guide to Dosing an mRNA Genital Herpes Vaccine. Viruses, 14.","DOI":"10.3390\/v14030540"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"7409","DOI":"10.1016\/j.vaccine.2020.09.079","article-title":"Protection against herpes simplex virus type 2 infection in a neonatal murine model using a trivalent nucleoside-modified mRNA in lipid nanoparticle vaccine","volume":"38","author":"LaTourette","year":"2020","journal-title":"Vaccine"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"eaaw7083","DOI":"10.1126\/sciimmunol.aaw7083","article-title":"Nucleoside-modified mRNA encoding HSV-2 glycoproteins C, D, and E prevents clinical and subclinical genital herpes","volume":"4","author":"Awasthi","year":"2019","journal-title":"Sci. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e152310","DOI":"10.1172\/JCI152310","article-title":"Trivalent nucleoside-modified mRNA vaccine yields durable memory B cell protection against genital herpes in preclinical models","volume":"131","author":"Awasthi","year":"2021","journal-title":"J. Clin. Invest."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Egan, K.P., Hook, L.M., Naughton, A., Pardi, N., Awasthi, S., Cohen, G.H., Weissman, D., and Friedman, H.M. (2020). An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection. PLoS Pathog., 16.","DOI":"10.1371\/journal.ppat.1008795"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/13\/3\/271\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:47:18Z","timestamp":1760028438000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/13\/3\/271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,5]]},"references-count":43,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["vaccines13030271"],"URL":"https:\/\/doi.org\/10.3390\/vaccines13030271","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,5]]}}}